Author:
Fromes Yves,Gounon P.,Veitia R.,Bissery M. C.,Fellous A.
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Organic Chemistry,Biochemistry,Bioengineering,Analytical Chemistry
Reference42 articles.
1. Albertini, D. F. (1984).In vivo andin vitro studies on the role of HMW-MAPs in taxol-induced microtubule bundling,Eur. J. Cell Biol. 33, 134–143.
2. Andreu, J. M., Diaz, J. F., Gil, R., de Pereda, J. M., de Lacoba, M. G., Peyrot, V., Briand, C., Towns-Andrews, E., and Bordas, J. (1994). Solution structure of Taxotere-induced microtubules,J. Biol. Chem. 269, 31785–31792.
3. Bissery, M. C., Guénard, D., Guéritte-Voegelein, F., and Lavelle, F. (1991). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue,Cancer Res. 51, 4845–4852.
4. Bissery, M. C., Nohynek, G., Sanderink, G., and Lavelle, F. (1995). Docetaxel (Taxotere®), a review of preclinical and clinical experience. Part I: Preclinical experience,Anticancer Drugs 6, 1–17.
5. Chang, A. Y., Kim, K., Glick, J.,et al. (1993). Phase II study of taxol, membarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group results,J. Natl. Cancer Inst. 85, 388.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献